Search Press releases Keywords From To 26 Jun 2009 Cimzia®, the only PEGylated anti-TNF, recommended for approval in the EU for rheumatoid arthritis Read More 24 Jun 2009 Jazz Pharmaceuticals and UCB announce second Phase III study of sodium oxybate in patients with fibromyalgia meets primary endpoints Read More 15 Jun 2009 UCB and PatientsLikeMe partner to give people with epilepsy a voice in advancing research Read More 29 May 2009 UCB receives CHMP positive opinion on bringing Neupro® back to all patients in Europe Read More 26 May 2009 UCB launches Vimpat® in the U.S. for add-on treatment of epilepsy in adults Read More 20 May 2009 Change in UCB's Executive Committee Read More Pagination First page Previous page Previous … Page 165 Page 166 Page 167 Page 168 Current page 169 Page 170 Page 171 Page 172 Page 173 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
